Lisa von Moltke, M.D.

Lisa von Moltke, M.D.

Executive Vice President and Chief Medical OfficeratSeres Therapeutics· In proxies 2022–2024

Pay in FY2024-19% from the year before · Seres Therapeutics stock -40.6% the same year

Lisa von Moltke, M.D. was paid $1.3M in FY2024 (Dec), down 19%. Seres Therapeutics stock fell 40.6% that year.

Pay$100 in the stock at the end of FY21 → $10
Pay is from the Summary Compensation Table of each Seres Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Seres TherapeuticsPublic company · 4 yr
    • Executive Vice President and Chief Medical Officer2022 – Present · 4 yrStock in role -99%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?